SH3Gl2 gene participates in MEK-ERK signal pathway partly by regulating EGFR in the laryngeal carcinoma cell line hep2

Medical Science Monitor

Volumn 16, Issue 6, 2010, Pages

  Shang, Chao ^a   Guo, Yan ^a   Fu, Shuang ^a   Fu, Weineng ^a   Sun, Kailai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; EGFR; ERK1 2; Laryngeal carcinoma; SH3GL2 gen

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PRIMER DNA; SH3GL2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INDUCTION; FLOW CYTOMETRY; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN SRC HOMOLOGY 3 DOMAIN GRB2-LIKE 2 GENE; LARYNX CARCINOMA; PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; LARYNGEAL NEOPLASMS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARYNGEAL NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MODELS, BIOLOGICAL; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 78049385706     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E et al: Cancer statistics. CA Cancer J Clin, 2007; 57: 43-66
2. Busquets JM, Garcia HA, Trinidad-Pinedo J et al: Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans. P R Health Sci J, 2003; 22: 259-64
3. Micozkadiog ̌lu D, Unal M, Pata YS et al: Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma. Med Sci Monit, 2008; 14(6): CR299-CR304
4. Fu WN, Shang C, Huang DF et al: Average-12.9 chromosome imbalances coupling with 15 differential expression genes possibly involved in the carcinogenesis, progression and metastasis of supraglottic laryngeal squamous cell cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006; 23: 7-11
5. Shang C, Fu WN, Xu ZM et al: Comparative genomic hybridization analysis of laryngeal carcinoma. Acta Genetica Sinica, 2004; 31: 539-544
6. Shang C, Fu WN, Guo Y et al: The study of the SH3GL2 gene expression in laryngeal carcinoma. Chines Medical Journal, 2007; 120: 385-388
7. Sparks AB, Hoffman NG, McConnell SJ et al: Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins. Nat Biotechnol, 1996; 14(6): 741-744
8. Schmidt A, Wolde M, Thiele C et al: Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid. Nature, 1999; 401(6749): 133-141
9. Hill E, van Der Kaay J, Downes CP et al: The role of dynamin and its binding partners in coated pit invagination and scission. J Cell Biol, 2001; 152(2): 309-323
10. Gad H, Ringstad N, Löw P et al: Fission and uncoating of synaptic clathrin- coated vesicles are perturbed by disruption of interactions with the SH3 domain of endophilin. Neuron, 2000; 27(2): 301-312
11. Tang Y, Hu LA, Miller WE et al: Identification of the endophilins (SH3p4/ p8/p13) as novel binding partners for the beta1-adrenergic receptor. Proc Natl Acad Sci USA, 1999; 96(22): 12559-12564
12. Ramjaun AR, Angers A, Legendre-Guillemin V et al: Endophilin regulates JNK activation through its interaction with the germinal center kinase-like kinase. J Biol Chem, 2001; 276(31): 28913-28993
13. Petrelli A, Gilestro GF, Lanzardo S et al: The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature, 2002; 416(6877): 187-190
14. Soubeyran P, Kowanetz K, Szymkiewicz I et al: Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature, 2002; 416(6877): 183-187
15. Endo H, Watanabe T, Sugioka Y et al: Activation of two distinct MAPK pathways governs constitutive expression of matrix metalloproteinase-1 in human pancreatic cancer cell lines. Int J Oncol, 2009; 35: 1237-1245
16. Shannon AM, Telfer BA, Smith PD et al: The mitogen-activated protein/ extracellular signal-regulated kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) enhances the radiation responsiveness of lung and colorectal tumor xenografts. Clin Cancer Res, 2009; 15: 6619-6629
17. Garavello W, Nicolini G, Aguzzi A et al: Selective reduction of extracellularsignal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx. Oncol Rep, 2006; 16: 479-484
18. Giachino C, Lantelme E, Lanzetti L et al: A novel SH3-containing human gene family preferentially expressed in the central nervous system. Genomics, 1997; 41(3): 427-434
19. Ringstad N, Nemoto Y, De Camilli P: The SH3p4/Sh3p8/SH3p13 protein family: binding partners for synaptojanin and dynamin via a Grb2-like Src homology 3 domain. Proc Natl Acad Sci USA, 1997; 94(16): 8569-8574
20. Nonis D, Schmidt MH, van de Loo S et al: Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cell Signal, 2008; 20: 1725-1739
21. Otsuki M, Itoh T, Takenawa T: Neural Wiskott-Aldrich syndrome protein is recruited to rafts and associates with Endophilin A in response to epidermal growth factor. J Biol Chem, 2003; 278: 6461-6469
22. Goumenos DS, Kalliakmani P, Tsakas S et al: Growth factors and apoptosis- related protein expression in human crescentic nephritis. Med Sci Monit, 2008; 14(11): BR243-BR248
23. Henson ES, Gibson SB: Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal, 2006; 18(12): 2089-2097
24. Starska K, Głowacka E, Lewy-Trenda I et al: EGFR immunoexpression and peripheral blood cytokine secretion as potential biomarkers of tumorbehavior in laryngeal squamous cell carcinoma. Med Sci Monit, 2009; 15(10): CR518-CR527
25. Perona R: Cell signalling: growth factors and tyrosine kinase receptors. Clin Transl Oncol, 2006; 8(2): 77-82
26. Kosaka T, Yatabe Y, Endoh H et al: Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res, 2004; 64(24): 8919-8923
27. Shtiegman K, Kochupurakkal BS, Zwang Y et al: Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling. Oncogene, 2007; 26: 6968-6978
28. Kirisits A, Pils D, Krainer M: Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways. Int J Biochem Cell Biol, 2007; 39(12): 2173-2182
29. Kaneko T, Maeda A, Takefuji M et al: Rho mediates endocytosis of epidermal growth factor receptor through phosphorylation of endophilin A1 by Rho-kinase. Genes Cell, 2005; 10: 973-987
30. Carter RE, Sorkin A: Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera. J Biol Chem, 1998; 273(52): 35000-35007
31. Marshall CJ: Signal transduction. Taking the Rap. Nature, 1998; 392(6676): 553-554
32. York RD, Yao H, Dillon T et al: Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature, 1998; 392(6676): 622-626
33. Dhillon AS, Hagan S, Rath O et al: MAP kinase signalling pathways in cancer. Oncogene, 2007; 26(22): 3279-3290
34. Garavello W, Nicolini G, Aguzzi A et al: Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx. Oncol Rep, 2006; 16: 479-484